We often have posts that research claims for Viraleze are not valid because Starpharma didn't arrange independant, large enough trials, and they lacked medical journal articles and the PEER REVIEW.
Seems in 2020 both The Lancet and New England Journal were caught out by fake peer reviews on two covid treatments which even claimed large FAKE worldwide data sets even including imaginary Australian Hospitals data and the means to check this info and its supposed de identification of included participants was all a con.
https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine most important factor was they they lacked "peer review"
Maybe the reported evidence for Viraleze efficacy reported at conferences, by Schripp Institute and the UK NHS Hosp Ashford St Peters study should inform TGA about the covid viral load reductions without waiting for Peer Review.
- Forums
- ASX - By Stock
- Is a Peer Review required for Viraleze covid viral load claim?
We often have posts that research claims for Viraleze are not...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
-0.002(2.04%) |
Mkt cap ! $40.06M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.6¢ | $279 | 2.903K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65644 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 34876 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65644 | 0.096 |
3 | 308325 | 0.095 |
4 | 360000 | 0.094 |
2 | 9659 | 0.093 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 34876 | 2 |
0.105 | 209291 | 3 |
0.110 | 168286 | 9 |
0.115 | 103400 | 3 |
0.120 | 79405 | 9 |
Last trade - 11.41am 08/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |